Correlation Between ADMA Biologics and Praxis Precision
Can any of the company-specific risk be diversified away by investing in both ADMA Biologics and Praxis Precision at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ADMA Biologics and Praxis Precision into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between ADMA Biologics and Praxis Precision Medicines, you can compare the effects of market volatilities on ADMA Biologics and Praxis Precision and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ADMA Biologics with a short position of Praxis Precision. Check out your portfolio center. Please also check ongoing floating volatility patterns of ADMA Biologics and Praxis Precision.
Diversification Opportunities for ADMA Biologics and Praxis Precision
0.73 | Correlation Coefficient |
Poor diversification
The 3 months correlation between ADMA and Praxis is 0.73. Overlapping area represents the amount of risk that can be diversified away by holding ADMA Biologics and Praxis Precision Medicines in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Praxis Precision Med and ADMA Biologics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ADMA Biologics are associated (or correlated) with Praxis Precision. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Praxis Precision Med has no effect on the direction of ADMA Biologics i.e., ADMA Biologics and Praxis Precision go up and down completely randomly.
Pair Corralation between ADMA Biologics and Praxis Precision
Given the investment horizon of 90 days ADMA Biologics is expected to generate 10.87 times less return on investment than Praxis Precision. But when comparing it to its historical volatility, ADMA Biologics is 8.48 times less risky than Praxis Precision. It trades about 0.13 of its potential returns per unit of risk. Praxis Precision Medicines is currently generating about 0.17 of returns per unit of risk over similar time horizon. If you would invest 5,429 in Praxis Precision Medicines on October 8, 2025 and sell it today you would earn a total of 22,263 from holding Praxis Precision Medicines or generate 410.08% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
ADMA Biologics vs. Praxis Precision Medicines
Performance |
| Timeline |
| ADMA Biologics |
| Praxis Precision Med |
ADMA Biologics and Praxis Precision Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with ADMA Biologics and Praxis Precision
The main advantage of trading using opposite ADMA Biologics and Praxis Precision positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ADMA Biologics position performs unexpectedly, Praxis Precision can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Praxis Precision will offset losses from the drop in Praxis Precision's long position.| ADMA Biologics vs. ACADIA Pharmaceuticals | ADMA Biologics vs. Praxis Precision Medicines | ADMA Biologics vs. Belite Bio ADR | ADMA Biologics vs. Ligand Pharmaceuticals Incorporated |
| Praxis Precision vs. Crinetics Pharmaceuticals | Praxis Precision vs. Soleno Therapeutics | Praxis Precision vs. Viking Therapeutics | Praxis Precision vs. Kymera Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Other Complementary Tools
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges |